Our ongoing coverage of Evans Sutherland (OOTC:ESCC) is a great example of the kind of hidden opportunities that many investors overlook. ESCC is an idea we brought to our premium members and has persistently paid off for us. The common strategy we […]
Shares of Repro Med (OOTC:REPR) are little changed following the company’s 2016 second quarter results. We view this as an encouraging sign that the market may finally be ready to shrug off the lingering issue of the FDA Warning letter that […]
Back in 2013, when we more regularly submitted publicly available content to Seeking Alpha, we wrote about a little-known and under-followed gem of a micro-cap stock, GTT Communications Inc. (NYSE:GTT) that provided some of the best stock returns to date. Part of […]
By Maj Soueidan, Co-founder GeoInvesting The bullish focus of this brief information arbitrage (“InfoArb”) piece is on Bluelinx Holdings Inc. (NYSE:BXC). Information arbitrage is one of the biggest opportunities in the microcap investing space. It exists when information that is public […]
On September 8, 2016, the Minister of Finance in China issued an announcement regarding an investigation and suggested punishment for five companies that were found to defraud the Chinese government for electric vehicle (“EV”) subsidies. This may Bloomberg reported this […]
The best investment theses are simple: Blue Bird Corporation (NASDAQ:BLBD) already has a committed buyer Note: We first published this article to members on the morning of July 27, 2016. We summarize why we think a takeover bid of around $13.00 […]
By Maj Soueidan, Co-founder of GeoInvesting GeoInvesting first noted bullish commentary in Continental Materials Corp (AMEX:CUO) Q1 2016 10-Q, prompting the team to start tracking the company in July 2016. The stock was trading at $16.97 at the time of the Premium Member Alert and now trades over […]
By Christopher Irons for GeoInvesting Mallinckrodt’s Acthar Gel may turn out to be the most appalling story in all of price gouging and it has gone completely unnoticed by politicians and the main stream media Price of the drug has […]